MTOR and cancer: Since many reports indicate that the 4E-BPs are functionally inactivated in cancer cells by major oncogenic signalling pathways [20], elucidation of the molecular mechanism involved in the mTOR-mediated regulation of 4E-BP degradation remains a major challenge.